The Headlines – Kenvue stock rebounds: Tylenol maker rises 6% after Donald Trump’s autism claims; analysts see limited legal impact

Kenvue shares rebounded after a sharp fall triggered by Donald Trump’s unfounded claims linking Tylenol to autism. Trump advised pregnant women to avoid the drug, despite a lack of new scientific evidence. Kenvue refuted the claims, while an analyst predicted limited lawsuit risks but cautioned about potential consumption decline due to negative publicity.

The Headlines – Latest Business News Today: Stock Markets, Financial News, India Business & World Business News – Read More